2007
DOI: 10.1016/j.ijporl.2006.12.016
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of early postoperative morbidity in pediatric tonsillectomy with the use of sucralfate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
34
1
1

Year Published

2012
2012
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(36 citation statements)
references
References 22 publications
0
34
1
1
Order By: Relevance
“…). Although designed for children aged 3–12 years to self‐report their pain, OUCHER has been used by observers (medical staff and parents) to assess pain intensity in infants aged 7–38 weeks after immunisation and in children aged 3–12 years after tonsillectomy …”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…). Although designed for children aged 3–12 years to self‐report their pain, OUCHER has been used by observers (medical staff and parents) to assess pain intensity in infants aged 7–38 weeks after immunisation and in children aged 3–12 years after tonsillectomy …”
Section: Methodsmentioning
confidence: 99%
“…Although designed for children aged 3-12 years to self-report their pain, OUCHER has been used by observers (medical staff and parents) to assess pain intensity in infants aged 7-38 weeks after immunisation 10 and in children aged 3-12 years after tonsillectomy. 11 Participant baseline FLACC and OUCHER scores were recorded by the participant's parent/guardian(s), the doctor performing the TUBC and the nurse assisting before commencement of the TUBC.…”
Section: Study Outcomesmentioning
confidence: 99%
“…In these patients, reduction of postoperative pain must be the most important goal of the clinician. There are some drugs used before, during or after the procedure to reduce postoperative pain after tonsillectomy [7][8][9][10][11]. Systemic paracetamol and non steroid antiinflamatory drugs are the most commonly used drugs for analgesia.…”
Section: Introductionmentioning
confidence: 99%
“…Sucralfate is an agent used in the treatment of peptic ulcer. It is believed to provide a protective barrier by its tendency to bind to exposed protein of the ulcer [9,10]. Also, there is evidence that sucralfate promotes local production of prostaglandin E2, thus increasing blood flow, mucous production, mitotic activity, and surface migration of cells.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation